Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus

By Hsu K.-H.L.   Crowe J.E.   Lubeck M.D.   Davis A.R.   Hung P.P.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 509-515

Elsevier

Access to resources Recommend Favorite

Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates

By Jin H.   Cheng X.   Traina-Dorge V.L.   Park H.J.   Zhou H.   Soike K.   Kemble G.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3647-3652

Elsevier

Access to resources Recommend Favorite

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

By Crowe J.E.   Bui P.T.   Siber G.R.   Elkins W.R.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 847-855

Elsevier

Access to resources Recommend Favorite

The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations

By Juhasz K.   Whitehead S.S.   Boulanger C.A.   Firestone C.-Y.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1416-1424

Elsevier

Access to resources Recommend Favorite

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

By Cano F.   Plotnicky-Gilquin H.   Nguyen T.N.   Liljeqvist S.   Samuelson P.   Bonnefoy J.-Y.   Stahl S.   Robert A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2743-2752

Elsevier

Access to resources Recommend Favorite